Panasonic Holdings Corporation - PCRFF

PCRFF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PCRFF	0	0.6	12.2	27.2	8.9	-0.6	-24.1	2.8	-23.4	-21.2
S&P 500	-1.4	-1.9	0.9	5.8	10.5	30.2	25.2	87.9	187.3	33109.7

Compare PCRFF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PCRFF
name	Panasonic Holdings Corporation
price	9.45
changes percentage	0
change	0
day low	9.45
day high	9.45
year high	10.82
year low	6.85
market cap	22061997963
price avg 50	8.64
price avg 200	8.64955
exchange	PNK
volume	250
avg volume	8454
open	9.45
previous close	9.45
eps	0.95
pe	9.95
earnings announcement	2025-01-31T05:00:00.000+0000
shares outstanding	2334602959
timestamp	2024-11-15 14:39:56

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 75.3%

Overall Quarterly Financial Health: 51.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000063271
revenue	8496420000000	8378942000000	1.40
gross profit	2342967000000	2261448000000	3.60
gross profit ratio	0.28	0.27	2.17
research and development expenses	491224000000	469785000000	4.56
operating expenses	1929156000000	1974310000000	-2.29
interest income	88972000000	48972000000	81.68
interest expense	24695000000	21133000000	16.86
ebitda	849918000000	719831000000	18.07
ebitdaratio	0.1	0.09	16.44
operating income	413811000000	288570000000	43.40
operating income ratio	0.05	0.03	41.42
net income	443994000000	265502000000	67.23
net income ratio	0.05	0.03	64.92
eps	190.16	113.75	67.17

Overall Score of Annual Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 8,496,420 million in 2024 from 8,378,942 million in 2023 representing a change of 1.4%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,342,967 million in 2024 from 2,261,448 million in 2023 representing a change of 3.6%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 491,224 million in 2024 from 469,785 million in 2023 representing a change of 4.56%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 1,929,156 million in 2024 from 1,974,310 million in 2023 representing a change of -2.29%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 849,918 million in 2024 from 719,831 million in 2023 representing a change of 18.07%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 413,811 million in 2024 from 288,570 million in 2023 representing a change of 43.4%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 443,994 million in 2024 from 265,502 million in 2023 representing a change of 67.23%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 190.16 in 2024 from 190.16 in 2023 representing a change of 67.17%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000063271
revenue	2121689000000	2196114000000	-3.39
gross profit	631164000000	637251000000	-0.96
gross profit ratio	0.3	0.29	2.52
research and development expenses	126730000000	130900000000	-3.19
operating expenses	547403000000	565637000000	-3.22
interest income	26890000000	21507000000	25.03
interest expense	5938000000	5757000000	3.14
ebitda	189788000000	166556000000	13.95
ebitdaratio	0.09	0.08	11.64
operating income	87285000000	71614000000	21.88
operating income ratio	0.04	0.03	26.16
net income	70633000000	44816000000	57.61
net income ratio	0.03	0.02	63.14
eps	30.25	19.2	57.55

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 2,121,689 million in 2025Q1 from 2,196,114 million in 2024Q4 representing a change of -3.39%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 631,164 million in 2025Q1 from 637,251 million in 2024Q4 representing a change of -0.96%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 126,730 million in 2025Q1 from 130,900 million in 2024Q4 representing a change of -3.19%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 547,403 million in 2025Q1 from 565,637 million in 2024Q4 representing a change of -3.22%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 189,788 million in 2025Q1 from 166,556 million in 2024Q4 representing a change of 13.95%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 87,285 million in 2025Q1 from 71,614 million in 2024Q4 representing a change of 21.88%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 70,633 million in 2025Q1 from 44,816 million in 2024Q4 representing a change of 57.61%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 30.25 in 2025Q1 from 30.25 in 2024Q4 representing a change of 57.55%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000063271
total assets	9411195000000	8059527000000	16.77
total liabilities	4689292000000	4269569000000	9.83
total equity	4721903000000	3789958000000	24.59
cash and cash equivalents	1119625000000	819499000000	36.62
short term investments	227456000000	169665000000	34.06
long term investments	631375000000	474226000000	33.14
total current assets	4152758000000	3802885000000	9.20
total non current assets	5258437000000	4256642000000	23.53
total current liabilities	3121687000000	2873420000000	8.64
total non current liabilities	1567605000000	1396149000000	12.28
common stock	259445000000	259274000000	0.07
retained earnings	3037982000000	2588800000000	17.35
total debt	1626279000000	1457107000000	11.61

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 9,411,195 million in 2024 from 8,059,527 million in 2023 representing a change of 16.77%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 4,721,903 million in 2024 from 3,789,958 million in 2023 representing a change of 24.59%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,119,625 million in 2024 from 819,499 million in 2023 representing a change of 36.62%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 227,456 million in 2024 from 169,665 million in 2023 representing a change of 34.06%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 4,152,758 million in 2024 from 3,802,885 million in 2023 representing a change of 9.2%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 259,445 in 2024 from 259,274 in 2023 representing a change of 0.07%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,037,982 million in 2024 from 2,588,800 million in 2023 representing a change of 17.35%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 4,689,292 million in 2024 from 4,269,569 million in 2023 representing a change of 9.83%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 3,121,687 million in 2024 from 2,873,420 million in 2023 representing a change of 8.64%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 1,626,279 million in 2024 from 1,457,107 million in 2023 representing a change of 11.61%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000063271
total assets	9874762000000	9411195000000	4.93
total liabilities	4818785000000	4689292000000	2.76
total equity	5055977000000	4721903000000	7.07
cash and cash equivalents	1118338000000	1119625000000	-0.11
short term investments	260588000000	227456000000	14.57
long term investments	632472000000	631375000000	0.17
total current assets	4454857000000	4152758000000	7.27
total non current assets	5419905000000	5258437000000	3.07
total current liabilities	3301728000000	3121687000000	5.77
total non current liabilities	1517057000000	1567605000000	-3.22
common stock	259445000000	259445000000	0.00
retained earnings	3072796000000	3037982000000	1.15
total debt	1579970000000	1626279000000	-2.85

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 9,874,762 million in 2025Q1 from 9,411,195 million in 2024Q4 representing a change of 4.93%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 5,055,977 million in 2025Q1 from 4,721,903 million in 2024Q4 representing a change of 7.07%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 260,588 million in 2025Q1 from 227,456 million in 2024Q4 representing a change of 14.57%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 4,454,857 million in 2025Q1 from 4,152,758 million in 2024Q4 representing a change of 7.27%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 3,072,796 million in 2025Q1 from 3,037,982 million in 2024Q4 representing a change of 1.15%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 1,579,970 million in 2025Q1 from 1,626,279 million in 2024Q4 representing a change of -2.85%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 4,818,785 million in 2025Q1 from 4,689,292 million in 2024Q4 representing a change of 2.76%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,118,338 million in 2025Q1 from 1,119,625 million in 2024Q4 representing a change of -0.11%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 3,301,728 million in 2025Q1 from 3,121,687 million in 2024Q4 representing a change of 5.77%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000063271
net change in cash	300126000000	-386374000000	177.68
operating cash flow	866898000000	520742000000	66.47
free cash flow	219699000000	150856000000	45.63
capital expenditure	-647199000000	-369886000000	-74.97
depreciation and amortization	399984000000	382289000000	4.63
deferred income tax	0	-210000000	100.00
stock based compensation	0	210000000	-100.00
accounts payables	-22111000000	5390000000	-510.22
inventory	152815000000	-120617000000	226.69
acquisitions net	15580000000	-4886000000	418.87
investments in property plant and equipment	-547470000000	-369886000000	-48.01
net cash used for investing activites	-578843000000	-344033000000	-68.25
debt repayment	113661000000	-424098000000	126.80
common stock issued	3000000	3000000	0.00
common stock repurchased	-52000000	-53000000	1.89
dividends paid	-75862000000	-70019000000	-8.34
net cash used provided by financing activities	-83494000000	-607013000000	86.25
cash at end of period	1119625000000	819499000000	36.62
accounts receivables	50554000000	25797000000	95.97
cash at beginning of period	819499000000	1205873000000	-32.04

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 300,126 million in 2024 from -386,374 million in 2023 representing a change of 177.68%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 866,898 million in 2024 from 520,742 million in 2023 representing a change of 66.47%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 219,699 million in 2024 from 150,856 million in 2023 representing a change of 45.63%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -647,199 million in 2024 from -369,886 million in 2023 representing a change of -74.97%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024 from 210 million in 2023 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024 from -210 million in 2023 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 22,111 million in 2024 from 5,390 million in 2023 representing a change of -510.22%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 50,554 in 2024 from 25,797 million in 2023 representing a change of 95.97%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -75,862 million in 2024 from -70,019 million in 2023 representing a change of -8.34%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000063271
operating cash flow	228000000000	268565000000	-15.10
free cash flow	30547000000	63874000000	-52.18
capital expenditure	-197453000000	-204691000000	3.54
depreciation and amortization	102503000000	104344000000	-1.76
deferred income tax	0	0	NaN
stock based compensation	0	318000000	-100.00
accounts receivables	80074000000	-54143000000	247.89
accounts payables	16532000000	-28423000000	158.16
inventory	-37862000000	125675000000	-130.13
acquisitions net	5261000000	-11659000000	145.12
investments in property plant and equipment	-197453000000	-204691000000	3.54
net cash used for investing activites	-214727000000	-205517000000	-4.48
debt repayment	0	4554000000	-100.00
common stock issued	0	2000000	-100.00
common stock repurchased	-10000000	-13000000	23.08
dividends paid	-40851000000	0	NaN
net cash used provided by financing activities	-77269000000	-38663000000	-99.85
net change in cash	-1287000000	81309000000	-101.58
cash at end of period	1118338000000	1119625000000	-0.11
cash at beginning of period	1119625000000	1038316000000	7.83

Overall Score of Quarterly Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,287 million in 2025Q1 from 81,309 million in 2024Q4 representing a change of -101.58%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 228,000 million in 2025Q1 from 268,565 million in 2024Q4 representing a change of -15.1%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 30,547 million in 2025Q1 from 63,874 million in 2024Q4 representing a change of -52.18%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -197,453 million in 2025Q1 from -204,691 million in 2024Q4 representing a change of 3.54%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 80,074 in 2025Q1 from -54,143 million in 2024Q4 representing a change of 247.89%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -40,851 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2025Q1 from 318 million in 2024Q4 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 16,532 million in 2025Q1 from 28,423 million in 2024Q4 representing a change of 158.16%. This indicates that the company has reduced its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2025 Earnings call transcript
Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	3638.96	3590.03	1.36
net income per share	190.16	113.76	67.16
operating cash flow per share	371.29	223.12	66.41
free cash flow per share	94.1	64.64	45.58
cash per share	576.95	423.82	36.13
book value per share	2022.36	1623.84	24.54
tangible book value per share	1172.7	854.23	37.28
shareholders equity per share	1946.2	1550.34	25.53
interest debt per share	587.12	527.21	11.36
market cap	3356502645360.68	2772532599690.21	21.06
enterprise value	3863156645360.68	3410140599690.21	13.28
pe ratio	7.56	10.44	-27.61
price to sales ratio	0.4	0.33	19.39
pocfratio	3.87	5.32	-27.28
pfcf ratio	15.28	18.38	-16.87
pb ratio	0.74	0.77	-3.60
ptb ratio	0.74	0.77	-3.60
ev to sales	0.45	0.41	11.72
enterprise value over ebitda	4.55	4.74	-4.05
ev to operating cash flow	4.46	6.55	-31.95
ev to free cash flow	17.58	22.61	-22.21
earnings yield	0.13	0.1	38.13
free cash flow yield	0.07	0.05	20.30
debt to equity	0.3	0.33	-11.36
debt to assets	0.14	0.15	-4.68
net debt to ebitda	0.6	0.89	-32.70
current ratio	1.33	1.32	0.52
interest coverage	16.76	13.65	22.72
income quality	1.95	1.86	5.19
dividend yield	0.02	0.03	-10.51
payout ratio	0.17	0.26	-35.21
sales general and administrative to revenue	0.25	0.23	6.57
research and ddevelopement to revenue	0.06	0.06	3.12
intangibles to total assets	0.21	0.22	-5.42
capex to operating cash flow	0.75	0.71	5.11
capex to revenue	0.08	0.04	72.55
capex to depreciation	1.62	0.97	67.23
stock based compensation to revenue	0	0.0	-100.00
graham number	2885.65	1992.01	44.86
roic	0.08	0.05	45.09
return on tangible assets	0.06	0.04	41.02
graham net net	-735.37	-704.42	-4.39
working capital	1031071000000	929465000000	10.93
tangible asset value	2738070000000	1993722000000	37.33
net current asset value	-536534000000	-466684000000	-14.97
invested capital	4844673000000	4136910000000	17.11
average receivables	1341821500000	1323605500000	1.38
average payables	1161532000000	1160243500000	0.11
average inventory	1248824500000	1210707500000	3.15
days sales outstanding	58.47	57.61	1.48
days payables outstanding	69.17	69.03	0.21
days of inventory on hand	71.71	76.89	-6.74
receivables turnover	6.24	6.34	-1.46
payables turnover	5.28	5.29	-0.21
inventory turnover	5.09	4.75	7.23
roe	0.1	0.07	33.16
capex per share	277.19	158.48	74.90

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 7.56 on 2024-03-31 from 10.44 on 2023-03-31, representing a change of -27.61%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.33 on 2024-03-31 from 1.32 on 2023-03-31, representing a change of 0.52%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.30 on 2024-03-31 from 0.33 on 2023-03-31, representing a change of -11.36%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
PCRFF
calendar year	2025	2024	NaN
revenue per share	908.66	940.78	-3.41
net income per share	30.25	19.2	57.56
operating cash flow per share	97.65	115.05	-15.13
free cash flow per share	13.08	27.36	-52.19
cash per share	590.55	577.07	2.34
book value per share	2165.32	2022.79	7.05
tangible book value per share	2165.32	1172.95	84.61
shareholders equity per share	2088.22	1946.62	7.27
interest debt per share	679.2	579.13	17.28
market cap	3083457579218.84	3355777058280.04	-8.11
enterprise value	3545089579218.84	3862431058280.04	-8.22
pe ratio	10.91	18.72	-41.70
price to sales ratio	1.45	1.53	-4.89
pocfratio	13.52	12.5	8.23
pfcf ratio	100.94	52.54	92.13
pb ratio	0.63	0.74	-14.37
ptb ratio	0.63	0.74	-14.37
ev to sales	1.67	1.76	-5.00
enterprise value over ebitda	18.68	23.19	-19.45
ev to operating cash flow	15.55	14.38	8.11
ev to free cash flow	116.05	60.47	91.92
earnings yield	0.02	0.01	71.53
free cash flow yield	0.01	0.02	-47.95
debt to equity	0.32	0.3	9.38
debt to assets	0.16	0.14	11.86
net debt to ebitda	2.43	3.04	-20.04
current ratio	1.35	1.33	1.43
interest coverage	14.7	12.44	18.17
income quality	3.23	5.99	-46.14
dividend yield	0.01	0	NaN
payout ratio	0.58	0	NaN
sales general and administrative to revenue	0	0.26	-100.00
research and ddevelopement to revenue	0.06	0.06	0.21
intangibles to total assets	0	0.21	-100.00
capex to operating cash flow	0.87	0.76	13.63
capex to revenue	0.09	0.09	-0.15
capex to depreciation	1.93	1.96	-1.80
stock based compensation to revenue	0	0.0	-100.00
graham number	1192.18	916.99	30.01
roic	0.01	0.01	-10.20
return on tangible assets	0.01	0.01	18.54
graham net net	-770.16	-735.53	-4.71
working capital	1153129000000	1031071000000	11.84
tangible asset value	5055977000000	2738070000000	84.65
net current asset value	-363928000000	-536534000000	32.17
invested capital	3158467000000	4844673000000	-34.81
average receivables	1345513000000	1312634000000	2.50
average payables	1186937500000	1171110000000	1.35
average inventory	1248526000000	1253711500000	-0.41
days sales outstanding	56.42	55.78	1.14
days payables outstanding	72.92	67.33	8.31
days of inventory on hand	77.78	69.79	11.44
receivables turnover	1.6	1.61	-1.13
payables turnover	1.23	1.34	-7.67
inventory turnover	1.16	1.29	-10.27
roe	0.01	0.01	46.88
capex per share	84.56	87.69	-3.56

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-06-30 Q1 from 0.01 on 2024-03-31 Q4, representing a change of 46.88%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 10.91 on 2024-06-30 Q1 from 18.72 on 2024-03-31 Q4, representing a change of -41.70%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.35 on 2024-06-30 Q1 from 1.33 on 2024-03-31 Q4, representing a change of 1.43%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.32 on 2024-06-30 Q1 from 0.30 on 2024-03-31 Q4, representing a change of 9.38%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 6.88 which is lower than current price 9.45, indicates the company may be overvalued.